Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking naproxen alongside Mounjaro (tirzepatide) is not formally contraindicated, but there are real reasons to be careful. Naproxen is an NSAID — a non-steroidal anti-inflammatory drug — and regular use of NSAIDs alongside Mounjaro carries a meaningful risk of kidney strain and gut irritation that both drugs can worsen independently. Your prescriber should know about any NSAID use before your treatment begins or continues. These are prescription-only medicines and clinical decisions; the guidance below covers what the evidence and UK clinical guidance actually say, so you can have an informed conversation with whoever manages your care.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks goes something like: "I take naproxen for my back, is that a problem with Mounjaro?" The honest answer is: it depends on how often you take it, your kidney function, and whether you stay well-hydrated.
Naproxen works by blocking prostaglandins, the molecules that cause inflammation. One side-effect of that mechanism is reduced blood flow to the kidneys. For most healthy adults who use naproxen occasionally, kidneys compensate easily. But Mounjaro can cause nausea, vomiting, and reduced fluid intake, particularly in the first weeks of treatment or after a dose increase. If you become even mildly dehydrated, the kidney-protective prostaglandins that naproxen suppresses matter more than usual. That combination raises the risk of what clinicians call acute kidney injury, even in people with previously normal kidney function.
There is also the gastric angle. NSAIDs are among the most common causes of stomach and duodenal irritation. Mounjaro slows gastric emptying, so food and any irritants (including naproxen) sit in the stomach longer. Some people on tirzepatide already experience reflux or indigestion; adding a regular NSAID can compound that. The NHS medicines information for tirzepatide advises telling your doctor or pharmacist about all medicines you take, specifically because of interactions like this one.
None of this means a single naproxen tablet is a crisis. It means that habitual or high-dose NSAID use alongside Mounjaro deserves prescriber oversight, not a pharmacy shelf decision.
Tirzepatide slows the rate at which the stomach empties its contents into the small intestine. For most oral medicines this effect is modest and clinically unimportant. With naproxen, the main concern is not that the drug fails to work (absorption is unlikely to be meaningfully reduced for a single dose) but that delayed gastric transit keeps naproxen in contact with the stomach lining for longer.
The BNF entry for tirzepatide notes the theoretical interaction with orally administered medicines whose absorption may be time-sensitive. For naproxen specifically, this is a secondary concern behind the kidney and GI risks, but it reinforces why your prescriber needs a full medicines history.
If you take naproxen for a chronic condition (arthritis, for example) your prescriber may consider whether a topical NSAID gel, paracetamol, or another approach could manage your symptoms during Mounjaro treatment without the systemic risks. That substitution decision belongs with them, not a search result. You can read more about what factors go into a Mounjaro assessment on our general eligibility overview.
For those managing pain alongside other health conditions, questions about heart or blood pressure medicines and Mounjaro come up similarly, the gastric-emptying effect is a thread worth understanding across your full medicines list.
Some people face more risk from this combination than others. If your kidneys already work at a reduced capacity (a situation explored in detail on our Mounjaro and CKD page) adding a regular NSAID is a significantly bigger concern. The same applies if you have heart failure, liver disease, or a history of peptic ulcers.
Older adults metabolise both drugs more slowly and are more vulnerable to NSAID-related kidney impairment and GI bleeding. If you are also on low-dose aspirin, anticoagulants, or corticosteroids, the bleeding risk from naproxen is compounded further.
Dehydration is the most immediate risk factor. Vomiting on a new or increased Mounjaro dose, combined with a naproxen tablet taken without adequate fluid, is exactly the scenario that tips kidney strain into something more serious. Signs to act on quickly include a significant reduction in urine output, swelling, or unusual fatigue. If you experience severe, persistent abdominal pain (particularly pain that moves toward the back) seek urgent medical attention, as this can indicate pancreatitis, a known though infrequent side effect of GLP-1 medicines that the MHRA highlighted in a Drug Safety Update in January 2026.
People who only need naproxen occasionally and have no kidney or GI history are in a different position from those who rely on it daily. That distinction is exactly why prescribers ask about medicines rather than issuing blanket rules. If BMI or eligibility questions are part of your thinking too, the Mounjaro BMI guidance page covers the licensed thresholds in full.
For occasional use (say, one or two tablets for a headache or muscle pain) the risk is low for most people on Mounjaro. Still, paracetamol is generally the safer first choice for mild pain on a GLP-1 medicine, simply because it does not carry the kidney or stomach-lining risks of NSAIDs. If ibuprofen is part of your usual rotation, our naproxen and ibuprofen comparison page sets out how the two NSAIDs compare in this context.
For anything beyond occasional use, speak to your prescriber before continuing. They may want to check your kidney function, review your full medicines list, and discuss whether a non-NSAID pain strategy fits your situation. This applies whether you are already taking Mounjaro or are about to start. You can learn more about the broader treatment picture on our Mounjaro overview page, including what to expect from a clinical review.
Supplement interactions are a separate but related area of enquiry; if you take other things alongside Mounjaro, our guide to supplements and Mounjaro adds useful context. And for anyone weighing up the private cost of treatment while working through these questions, the Mounjaro pricing page sets out what a full private prescription actually involves.
If you are ready to discuss your full medicines history with a clinician, you can start your free consultation with our GPhC-registered prescribers today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.